// App-Quantinova.ai

1207M-05 : LATE CLINICAL OUTCOMES AFTER BIORESORBABLE OR PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: 2-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL

Researchers

Presenter

  • Dean J. Kereiakes

Principal Investigators

  • Ian Meredith

  • Stephan Windecker

  • Thomas Christen

  • Ameer Kabour

  • Alain Bouchard

  • Annapoorna Kini

  • Luc Janssens

  • Michael Foster

  • Robert Stoler

  • Thomas Stuckey

  • Wayne Batchelor

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Coronary artery lesions

  • Myocardial infarction

  • Neoatherosclerosis

  • Venous thrombosis

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved